Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04704154
Title A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Bayer

esophagus squamous cell carcinoma


anaplastic astrocytoma

intrahepatic cholangiocarcinoma

head and neck squamous cell carcinoma

gallbladder cancer


malignant astrocytoma

oropharynx cancer

pancreatic ductal adenocarcinoma


Nivolumab + Regorafenib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | BEL

Additional content available in CKB BOOST